Rheumatologists practicing in rural and urban areas face different challenges. Robert Jackson, DO, discusses how technology, healthcare reform and hospital closures affect rheumatology practice in rural areas and its future…
How are Annie and Abby? That’s a question some patients ask J. Michelle Kahlenberg, MD, PhD, a rheumatologist and assistant professor in the school of medicine at the University of Michigan, who also runs a lupus research lab at the University of Michigan Health System. Patients aren’t asking about her children, but family members of…
Steven S. Overman, MD, MPH, shares medical knowledge, supplies, and clinical practice expertise with locals in rewarding visit to Nepal’s Upper Mustang region
Signed into law in April, the legislation will ban direct and indirect PBM ownership of pharmacies, effective Jan. 1, 2026. It addresses longstanding concerns about conflicts of interest, market consolidation and patient access created by vertically integrated PBM pharmacy models.
Katherine Terracina, MD, & Prajakta P. Masurkar, PhD |
In addition to the impediments to consistent, high-quality care suffered by all incarcerated individuals, incarcerated patients with rheumatic disease face challenges specific to the treatment, management & monitoring of rheumatic conditions.
Incoming Arthritis & Rheumatology Editor-in-Chief Dr. S. Louis Bridges Jr., MD, PhD, discusses his path to rheumatology and outlines his vision for the journal.
The bill also enhances the state’s service cancelable loan program to help address critical shortages in the healthcare workforce. Much of the language draws from model policy previously developed by the ACR.
In visits to Congress members and staff, more than 120 ACR/ARP members and patients urged action to improve patient access to quality treatment. The meetings included discussions about the importance of research funding, ensuring adequate Medicare reimbursement, protecting Medicaid, and making PBMs more transparent and accountable. It’s not too late to amplify their message.